Chemours Net Working Capital from 2010 to 2026
| CC Stock | USD 20.52 0.10 0.49% |
Net Working Capital | First Reported 2020-03-31 | Previous Quarter 1.2 B | Current Value 1.3 B | Quarterly Volatility 150.7 M |
Check Chemours financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chemours' main balance sheet or income statement drivers, such as Depreciation And Amortization of 311.8 M, Interest Expense of 157.1 M or Selling General Administrative of 786.3 M, as well as many indicators such as Price To Sales Ratio of 0.54, Dividend Yield of 0.0433 or PTB Ratio of 8.14. Chemours financial statements analysis is a perfect complement when working with Chemours Valuation or Volatility modules.
Chemours | Net Working Capital | Build AI portfolio with Chemours Stock |
Analyzing Chemours's Net Working Capital over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Working Capital has evolved provides context for assessing Chemours's current valuation and future prospects.
Latest Chemours' Net Working Capital Growth Pattern
Below is the plot of the Net Working Capital of Chemours Co over the last few years. It is Chemours' Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chemours' overall financial position and show how it may be relating to other accounts over time.
| Net Working Capital | 10 Years Trend |
|
Net Working Capital |
| Timeline |
Chemours Net Working Capital Regression Statistics
| Arithmetic Mean | 1,551,617,647 | |
| Geometric Mean | 1,521,644,330 | |
| Coefficient Of Variation | 19.81 | |
| Mean Deviation | 279,934,256 | |
| Median | 1,584,000,000 | |
| Standard Deviation | 307,320,420 | |
| Sample Variance | 94445.8T | |
| Range | 744.3M | |
| R-Value | (0.90) | |
| Mean Square Error | 19699.1T | |
| R-Squared | 0.80 | |
| Slope | (54,585,049) | |
| Total Sum of Squares | 1511133.4T |
Chemours Net Working Capital History
About Chemours Financial Statements
Chemours stakeholders use historical fundamental indicators, such as Chemours' Net Working Capital, to determine how well the company is positioned to perform in the future. Although Chemours investors may analyze each financial statement separately, they are all interrelated. For example, changes in Chemours' assets and liabilities are reflected in the revenues and expenses on Chemours' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Chemours Co. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Working Capital | 1.1 B | 1.1 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out the analysis of Chemours Correlation against competitors. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Will Diversified Chemicals sector continue expanding? Could Chemours diversify its offerings? Factors like these will boost the valuation of Chemours. Projected growth potential of Chemours fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Chemours data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.65) | Dividend Share 0.675 | Earnings Share (2.13) | Revenue Per Share | Quarterly Revenue Growth (0.01) |
Understanding Chemours requires distinguishing between market price and book value, where the latter reflects Chemours's accounting equity. The concept of intrinsic value - what Chemours' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Chemours' price substantially above or below its fundamental value.
It's important to distinguish between Chemours' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Chemours should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Chemours' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.